Details

Autor(en) / Beteiligte

• SAW, Jacqueline
• BHATT, Deepak L
• SHEIKH, Mobeen A
• KEREIAKES, Dean J
• TOPOL, Eric J
• MOLITERNO, David J
• BRENER, Sorin J
• STEINHUBL, Steven R
• LINCOFF, A. Michael
• TCHENG, James E
• HARRINGTON, Robert A
• SIMOONS, Maarten
• TINGFEI HU

Titel

The influence of peripheral arterial disease on outcomes : A pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials

Ist Teil von

• Journal of the American College of Cardiology, 2006-10, Vol.48 (8), p.1567-1572

Ort / Verlag

New York, NY: Elsevier Science

Erscheinungsjahr

2006

Quelle

MEDLINE

Beschreibungen/Notizen

• We aimed to evaluate clinical outcomes among peripheral arterial disease (PAD) patients following percutaneous coronary intervention (PCI). A significant proportion of patients with coronary artery disease undergoing PCI have concomitant PAD, which may be associated with worse outcomes. We performed a pooled analysis of 8 randomized PCI trials. We included multicenter PCI trials that compared antiplatelet therapies (EPIC, EPILOG, EPISTENT, RAPPORT, CAPTURE, IMPACT-II, TARGET, and CREDO) and had baseline PAD status recorded. Multivariable analyses were performed with stepwise logistic regression for 7- and 30-day outcomes and Cox regression for 6-month and 1-year events. In our pooled analysis of 19,867 patients undergoing PCI, 1,602 (8.1%) were previously diagnosed with PAD. Patients with PAD had higher incidences of 7-day death (1.0% vs. 0.4%; p < 0.001) or myocardial infarction (MI) (6.8% vs. 5.6%; p = 0.047), 30-day death (1.7% vs. 0.7%; p < 0.001) or MI (7.4% vs. 6.1%; p = 0.05), 6-month death (4.2% vs. 1.5%; p < 0.001) or MI (9.1%, vs. 7.7%; p = 0.048), and 1-year death (5.0% vs. 2.1%; p < 0.001). There was a trend toward higher major bleeding risk with PAD (4.8% vs. 3.9%; p = 0.06). With multivariable analyses, PAD remains a significant predictor of mortality at 30 days (hazard ratio [HR] 1.67, 95% confidence interval [CI] 1.03 to 2.70; p = 0.039), 6 months (HR 1.76, 95% CI 1.31 to 2.37; p < 0.001), and 1 year (HR 1.46, 95% CI 1.08 to 1.96; p = 0.013). The presence of PAD is associated with higher rates of post-PCI death and MI, and is an independent predictor of short- and long-term mortality.